BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6139388)

  • 1. A high molecular weight form of somatostatin-28 (1-12)-like immunoreactive substance without somatostatin-14 immunoreactivity in the rat pancreas. Evidence that somatostatin-14 synthesis can occur independently of somatostatin-28.
    Patel YC
    J Clin Invest; 1983 Dec; 72(6):2137-43. PubMed ID: 6139388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
    Patel YC; Ganda OP; Benoit R
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of tissue and releasable molecular forms of somatostatin-28[1-12]-like immunoreactivity in rat median eminence.
    Charpenet G; Patel YC
    Endocrinology; 1985 May; 116(5):1863-8. PubMed ID: 2859191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides derived by processing of rat prosomatostatin near the amino-terminus: characterization, tissue distribution, and release.
    Rabbani SN; Patel YC
    Endocrinology; 1990 Apr; 126(4):2054-61. PubMed ID: 1969342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement and characterization of somatostatin-14-like immunoreactivity in human urine.
    Rabbani SN; Patel YC
    J Clin Endocrinol Metab; 1988 May; 66(5):1050-5. PubMed ID: 2896203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic polypeptide and other pancreatic hormones in spontaneously diabetic BB/W rats.
    Tomita T; Doull V; Fredrickson D; Pollock G
    Pancreas; 1990 Nov; 5(6):658-67. PubMed ID: 1980735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine induces a loss of tissue somatostatin-28 when measured as somatostatin-28(15-28)-like immunoreactivity but not when assessed as somatostatin-28(1-14)-like immunoreactivity: evidence for the importance of the disulfide bond for cysteamine action.
    Patel YC; Pierzchala I
    Endocrinology; 1985 May; 116(5):1699-702. PubMed ID: 2859189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides derived from cleavage of prosomatostatin at carboxyl- and amino-terminal segments. Characterization of tissue and secreted forms in the rat.
    Patel YC; O'Neil W
    J Biol Chem; 1988 Jan; 263(2):745-51. PubMed ID: 2891703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin-28 [1-12]-like peptides.
    Benoit R; Bohlen P; Ling N; Esch F; Baird A; Ying SY; Wehrenberg WB; Guillemin R; Morrison JH; Bakhit C
    Adv Exp Med Biol; 1985; 188():89-107. PubMed ID: 2863951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.
    Kohnert KD; Kändler C; Woltanski KP; Ziegler M
    Exp Clin Endocrinol; 1985 Feb; 85(1):89-94. PubMed ID: 2985414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin-like immunoreactivity (SLI) in pancreatic and intestinal tissues of the duck. A possible origin for the portal circulating SLI.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    Horm Metab Res; 1985 Nov; 17(11):566-71. PubMed ID: 2867025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin-28(1-12)-like immunoreactivity in the rat.
    Benoit R; Ling N; Bakhit C; Morrison JH; Alford B; Guillemin R
    Endocrinology; 1982 Dec; 111(6):2149-51. PubMed ID: 7140652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of immunoreactive somatostatin from fish pancreatic islets.
    Oyama H; Hirsch HJ; Gabbay KH; Permutt A
    J Clin Invest; 1980 May; 65(5):993-1002. PubMed ID: 6102573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of glucagon in the gastrointestinal tract.
    Sasaki H; Rubalcava B; Baetens D; Blazquez E; Srikant CB; Orci L; Unger RH
    J Clin Invest; 1975 Jul; 56(1):135-45. PubMed ID: 237936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and molecular forms of peptides containing somatostatin immunodeterminants in extracts from the entire gastrointestinal tract of man and pig.
    Baldissera FG; Holst JJ; Jensen SL; Krarup T
    Biochim Biophys Acta; 1985 Jan; 838(1):132-43. PubMed ID: 2857096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic metabolism of somatostatin-14 and somatostatin-28: immunochemical characterization of the metabolic fragments and comparison of cleavage sites.
    Ruggere MD; Patel YC
    Endocrinology; 1985 Jul; 117(1):88-96. PubMed ID: 2861082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of somatostatin-14 and somatostatin-28 gastrointestinal-pancreatic cells of rats and humans.
    Francis BH; Baskin DG; Saunders DR; Ensinck JW
    Gastroenterology; 1990 Nov; 99(5):1283-91. PubMed ID: 1976560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin-like immunoreactivity in pancreatic extracts of a sahelian lizard (Varanus exanthematicus) during starvation.
    Dupé-Godet M; Adjovi Y
    Comp Biochem Physiol A Comp Physiol; 1983; 75(3):347-52. PubMed ID: 6136368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic production of somatostatin-like immuno- and bioactivity by cultured human pulmonary small cell carcinoma.
    Szabo M; Berelowitz M; Pettengill OS; Sorenson GD; Frohman LA
    J Clin Endocrinol Metab; 1980 Nov; 51(5):978-87. PubMed ID: 6106652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of synthetic somatostatin-28 and a related endogenous rat hypothalamic somatostatin-like molecule by hypothalamic enzymes.
    Zingg HH; Patel YC
    Life Sci; 1982 Feb; 30(6):525-33. PubMed ID: 6122155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.